AI Wiki · Mediocre Security
Company#science

Isomorphic Labs

Alphabet's AI drug-discovery company, spun out of Google DeepMind and led by Demis Hassabis; raised a $5B Series C in November 2026 to take drug candidates into clinical trials.

Isomorphic Labs is the Alphabet company that applies Google DeepMind’s structure-prediction work to drug discovery. Demis Hassabis runs it alongside DeepMind, and it has partnerships with Eli Lilly, Novartis and Johnson & Johnson.

Funding

On Nov 17 2026 it raised a $5B Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining and existing investors including GV, CapitalG, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund. It did not disclose a valuation; Bloomberg had reported talks at about $50B (as relayed by TechCrunch). The round, which follows a $2.1B Series B in May 2026, is meant to take its drug candidates into clinical trials.

Timeline

Every dated event in the wiki that involves Isomorphic Labs, newest first.

Connections

Isomorphic Labs and everything one link away. Drag to move, scroll to zoom, click a node to open it.Open in the full graph →

Sources

  1. TechCrunch, “Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials”, Nov 17 2026